A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of Setileuton [MK0633] in Adult Patients With Chronic Asthma.

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of Setileuton [MK0633] in Adult Patients With Chronic Asthma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Setileuton (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2011 Additional trial locations (Czech Republic, Hungary) identified as reported by European Clinical Trials Database.
    • 02 Jun 2009 Actual patient number (688) added as reported by ClinicalTrials.gov.
    • 02 Jun 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top